Published in Crit Care on April 28, 2010
Glutamate for Metabolic Intervention in Coronary Surgery II (GLUTAMICSII) | NCT02592824
Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care (2010) 1.18
Levosimendan: current data, clinical use and future development. Heart Lung Vessel (2013) 0.95
Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care (2011) 0.93
High levels of B-type natriuretic peptide predict weaning failure from mechanical ventilation in adult patients after cardiac surgery. Clinics (Sao Paulo) (2013) 0.89
Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg (2011) 0.86
Optimal perioperative management of arterial blood pressure. Integr Blood Press Control (2014) 0.82
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. J Zhejiang Univ Sci B (2013) 0.81
Dual presentation of a giant left ventricular pseudoaneurysm and true aneurysm. Proc (Bayl Univ Med Cent) (2012) 0.81
Methylene blue modulates transendothelial migration of peripheral blood cells. PLoS One (2013) 0.78
Tissue oxygen saturation as an early indicator of delayed lactate clearance after cardiac surgery: a prospective observational study. BMC Anesthesiol (2015) 0.77
Catecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey. PLoS One (2014) 0.75
Baroreflex sensitivity and outcomes following coronary surgery. PLoS One (2017) 0.75
Perioperative care in older adults. J Geriatr Cardiol (2015) 0.75
Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg. BMC Anesthesiol (2016) 0.75
Risk factors of postcardiotomy ventricular dysfunction in moderate-to-high risk patients undergoing open-heart surgery. Ann Card Anaesth (2017) 0.75
European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg (1999) 17.03
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation (1989) 6.28
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J (2006) 4.57
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA (1992) 3.48
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation (1995) 3.02
Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med (2004) 2.35
Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology (2008) 2.33
Retracted A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth (2008) 2.32
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol (2006) 2.26
[The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol (2008) 2.22
Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology (2004) 2.14
Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology (2003) 2.12
Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth (2007) 2.02
Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review. Crit Care (2004) 2.00
The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg (2007) 1.97
Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology (2002) 1.93
Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology (2003) 1.89
Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth (2009) 1.84
The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail (2003) 1.82
Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J (2006) 1.80
The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg (2001) 1.69
The Chinese coronary artery bypass grafting registry study: how well does the EuroSCORE predict operative risk for Chinese population? Eur J Cardiothorac Surg (2008) 1.62
Central venous pressure, pulmonary artery occlusion pressure, intrathoracic blood volume, and right ventricular end-diastolic volume as indicators of cardiac preload. J Crit Care (1996) 1.61
Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth (2009) 1.57
Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg (1995) 1.56
Comparison between an empirically derived model and the EuroSCORE system in the evaluation of hospital performance: the example of the Italian CABG Outcome Project. Eur J Cardiothorac Surg (2008) 1.52
Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med (1984) 1.52
Limitations of EuroSCORE for measurement of risk-stratified mortality in aortic arch surgery using selective cerebral perfusion: is advanced age no longer a risk? Ann Thorac Surg (2006) 1.49
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail (2006) 1.45
Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg (1996) 1.40
Inoprotection: the perioperative role of levosimendan. Anaesth Intensive Care (2007) 1.40
Impact of routine use of intraoperative transesophageal echocardiography during cardiac surgery. Can J Anaesth (2000) 1.36
Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J (2006) 1.30
Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg (2005) 1.29
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg (2000) 1.28
High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg (2008) 1.27
Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol (2004) 1.26
Acute right ventricular failure--from pathophysiology to new treatments. Intensive Care Med (2003) 1.22
The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk? Heart (2006) 1.22
Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail (2005) 1.17
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg (1999) 1.16
Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation (2005) 1.15
The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth (2007) 1.12
Assessment of intrathoracic blood volume as an indicator of cardiac preload: single transpulmonary thermodilution technique versus assessment of pressure preload parameters derived from a pulmonary artery catheter. J Cardiothorac Vasc Anesth (2001) 1.10
Central venous pressure, pulmonary capillary wedge pressure and intrathoracic blood volumes as preload indicators in cardiac surgery patients. Eur J Cardiothorac Surg (1998) 1.09
Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth (2001) 1.08
A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg (2003) 1.03
Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. J Thorac Cardiovasc Surg (1992) 1.02
Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg (1986) 0.97
Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol (2008) 0.96
Quality of care in adult heart surgery: proposal for a self-assessment approach based on a French multicenter study. Eur J Cardiothorac Surg (1995) 0.94
Assessing open heart surgery mortality in Catalonia (Spain) through a predictive risk model. Eur J Cardiothorac Surg (1997) 0.93
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol (2004) 0.93
Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg (1992) 0.93
Functional hemodynamic monitoring and dynamic indices of fluid responsiveness. Minerva Anestesiol (2008) 0.93
Assessment of cardiac preload by indicator dilution and transoesophageal echocardiography. Eur J Anaesthesiol (2001) 0.91
Prediction of volume response under open-chest conditions during coronary artery bypass surgery. Crit Care (2007) 0.90
Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth (1999) 0.90
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth (2006) 0.89
The EuroSCORE risk stratification system in the current era: how accurate is it and what should be done if it is inaccurate? Eur J Cardiothorac Surg (2008) 0.88
Changes in central venous pressure and pulmonary capillary wedge pressure do not indicate changes in right and left heart volume in patients undergoing coronary artery bypass surgery. Eur J Anaesthesiol (1999) 0.86
Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg (1988) 0.86
Comparison of xenon-based anaesthesia compared with total intravenous anaesthesia in high risk surgical patients. Anaesthesia (2005) 0.85
Ventricular function after normothermic versus hypothermic cardioplegia. J Thorac Cardiovasc Surg (1993) 0.85
Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth (1992) 0.83
Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis. Circulation (2008) 0.83
Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation (1984) 0.83
The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade. Thorac Cardiovasc Surg (1995) 0.82
The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg (2002) 0.81
Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand (2007) 0.80
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther (1999) 0.80
Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth (2005) 0.79
Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth (1992) 0.79
Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine? Intensive Care Med (1997) 0.78
Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest (1994) 0.78
Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery. Eur J Anaesthesiol Suppl (1993) 0.78
B-type natriuretic peptide for diagnosis and therapy. Recent Pat Cardiovasc Drug Discov (2008) 0.78
Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther (2004) 0.78
Dopamine and high-dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: effects on myocardial metabolism. Ann Thorac Surg (1991) 0.78
Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure. Swiss Med Wkly (2009) 0.78
A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesth Analg (1998) 0.77
Low-output syndrome after heart surgery: is a monotherapy with phosphodiesterase-III inhibitors feasible? A comparative study of amrinone and enoximone. Thorac Cardiovasc Surg (1992) 0.77
An unusual case of cardiac dysfunction after left ventricular reconstruction. J Cardiothorac Surg (2006) 0.76
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med (2003) 7.64
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med (2009) 5.26
EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia (2008) 5.22
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J (2006) 4.57
A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. N Engl J Med (2015) 4.22
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2013) 4.04
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet (2011) 3.93
Acute myocardial infarction. Lancet (2003) 3.59
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J (2004) 3.45
Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care (2006) 3.43
N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology (2007) 3.38
Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med (2007) 3.28
Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med (2015) 3.27
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med (2004) 2.98
Long-term outcomes of bilateral lobar lung transplantation. Eur J Cardiothorac Surg (2012) 2.76
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
Prediction of movement to surgical stimulation by the pupillary dilatation reflex amplitude evoked by a standardized noxious test. Anesthesiology (2015) 2.61
Association of gender and lowest hematocrit on cardiopulmonary bypass with acute kidney injury and operative mortality in patients undergoing cardiac surgery. Ann Thorac Surg (2013) 2.60
Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol (2012) 2.57
Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol (2003) 2.56
Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med (2008) 2.51
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg (2007) 2.37
Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg (2007) 2.34
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg (2006) 2.33
Thoracic epidural versus intravenous patient-controlled analgesia after cardiac surgery: a randomized controlled trial on length of hospital stay and patient-perceived quality of recovery. Anesthesiology (2006) 2.30
Catamenial pneumothorax revisited: clinical approach and systematic review of the literature. J Thorac Cardiovasc Surg (2004) 2.26
Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth (2010) 2.26
Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J (2008) 2.22
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr (2008) 2.19
Pro: Beta-blockers are indicated for patients at risk for cardiac complications undergoing noncardiac surgery. Anesth Analg (2007) 2.16
Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth (2012) 2.15
Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg (2002) 2.11
Thoracoscopic treatment of pulmonary sequestration. Eur J Cardiothorac Surg (2006) 2.09
The obesity paradox in patients with peripheral arterial disease. Chest (2008) 2.09
Anaphylactic shock decreases cerebral blood flow more than what would be expected from severe arterial hypotension. Shock (2012) 2.08
Comparison of spectral entropy and bispectral index electroencephalography in coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2009) 2.07
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg (2008) 2.06
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res (2008) 2.06
Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology (2010) 2.04
Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth (2007) 2.02
O2, anybody? Eur J Anaesthesiol (2015) 1.99
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience. J Thorac Oncol (2015) 1.99
Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis (2007) 1.98
A word of caution: risk of device erosion after percutaneous treatment of atrial septal defect in patients with dilated aortic root. Circulation (2014) 1.97
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg (2014) 1.90
Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function. J Hypertens (2006) 1.88
Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology (2011) 1.87
Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med (2004) 1.82
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J (2008) 1.81
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol (2009) 1.81
Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J (2006) 1.79
CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg (2011) 1.76
Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg (2007) 1.75
The myocardial band: fiction or fact? Eur J Cardiothorac Surg (2005) 1.70
Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg (2009) 1.68
Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study. J Nucl Cardiol (2003) 1.67
Acute renal failure is NOT an "acute renal success"--a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med (2010) 1.67
Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise. J Physiol (2002) 1.66
The BODE index after lung volume reduction surgery correlates with survival. Chest (2006) 1.66
Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg (2012) 1.65
Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med (2009) 1.65
Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol (2015) 1.64
Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit Care Med (2013) 1.64
Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Eur J Cardiothorac Surg (2013) 1.63
Impact of surgical ventricular restoration on diastolic function: implications of shape and residual ventricular size. Ann Thorac Surg (2008) 1.60
Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg (2009) 1.60
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. Eur J Heart Fail (2011) 1.60
Perioperative beta blockade: where do we go from here? Lancet (2008) 1.59
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg (2010) 1.59
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol (2014) 1.59
Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int J Cardiol (2011) 1.57
Guidelines for cardiac management in noncardiac surgery are poorly implemented in clinical practice: results from a peripheral vascular survey in the Netherlands. Anesthesiology (2007) 1.57
Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg (2009) 1.57
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol (2004) 1.57
Accuracy, calibration and clinical performance of the new EuroSCORE II risk stratification system. Eur J Cardiothorac Surg (2012) 1.57
Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med (2005) 1.56
Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med (2005) 1.56
Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med (2011) 1.54
C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb Haemost (2008) 1.53
Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg (2012) 1.53
Tolerance to acute isovolemic hemodilution. Effect of anesthetic depth. Anesthesiology (2003) 1.53
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol (2008) 1.53
Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J (2010) 1.52
Performance analysis of interactive multimodal CME retraining on attitude toward and application of OPCAB. J Thorac Cardiovasc Surg (2006) 1.52
L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr (2012) 1.52
Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand (2009) 1.52
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med (2004) 1.51
Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology (2005) 1.51